|
||||||||||||
|
||||||||||||
![]() ![]()
|
Illness and Conditions - DrugDetail
Examples
These are all corticosteroid medicines that you take by mouth (orally) in tablet form. Decadron is available as a liquid. Why It Is UsedThese medicines are usually used for polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). They can quickly reduce inflammation caused by these conditions. Higher doses of corticosteroids are taken for giant cell arteritis than for polymyalgia rheumatica. How Well It WorksMost people with polymyalgia rheumatica or giant cell arteritis respond quickly to corticosteroid treatment and can usually stop taking the medicine after 1 to 2 years.1, 2 Some people keep taking low doses of corticosteroids for several years to control symptoms such as pain and stiffness.1 Side EffectsWith long-term use, common side effects may include:
Uncommon side effects include:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.) What To Think AboutLower-dose corticosteroids (generally 5 mg to 20 mg per day) cause fewer side effects and have fewer long-term risks than do higher dosages (40 mg to 60 mg per day). Your doctor will give you as low a dose as possible to treat your condition. After your symptoms have gone away and your lab tests are normal, your doctor will slowly reduce your dosage over a period of months. If you need long-term corticosteroid treatment for either condition, you are at risk for bone thinning (osteoporosis). This is because corticosteroids reduce how well your body takes in calcium, which is important in building bones. To prevent osteoporosis, doctors recommend taking 1000 mg to 1500 mg of calcium and 800 IU of vitamin D daily. You may also need medicine that prevents osteoporosis, such as alendronate or risedronate. Postmenopausal women can help reduce their risk of osteoporosis by lifting weights or using hormone replacement therapy. For more information, see the topic Osteoporosis.
Complete the
new medication information form (PDF) References
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||